Back to Journals » OncoTargets and Therapy » Volume 11

Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to date

Total article views   HTML views PDF downloads Totals
16,062 Dovepress* 11,574+ 1,412 12,986
PubMed Central* 4,488 940 5,428
Totals 16,062 2,352 18,414
*Since 22 August 2018
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 1 2 4

View citations on PubMed Central and Google Scholar